Print Page   |   Sign In   |   Register
News & Press: What's NEWs at AIM

ACIP Workgroup Survey Results: HPV 9-45 yrs

Thursday, February 28, 2019  
Share |
ACIP Workgroup Survey Results: HPV 9-45 yrs
The ACIP HPV workgroup asked for awardee feedback on FDA’s expanded age range for 9-valent HPV vaccine to men and women through age 45 years. AIM conducted a survey to gather member feedback on the programmatic impact of an ACIP recommendation. 45 of 64 (64%) of Immunization Programs responded to the survey. Survey results (HPV 9-45 yrs) were communicated at the February ACIP meeting. Thank you AIM members for helping us communicate the collective voice of AIM!

Community Search
Sign In


Latest News
Calendar

AIM Corporate Alliance